Circulating interleukin-10 and interleukin-12 in Parkinson's disease

Acta Neurologica Scandinavica

Volumn 119, Issue 5, 2009, Pages 332-337

  Rentzos, M ^a   Nikolaou, C ^a   Andreadou, E ^a   Paraskevas, G P ^a   Rombos, A ^a   Zoga, M ^a   Tsoutsou, A ^a   Boufidou, F ^a   Kapaki, E ^a   Vassilopoulos, D ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

ELISA; IL 10; IL 12; Immunological disturbances; l dopa treatment; Parkinson's disease; Serum

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12;

AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNITY; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PARKINSON DISEASE; PATHOGENESIS; RATING SCALE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHEMOTAXIS, LEUKOCYTE; CYTOPROTECTION; ENCEPHALITIS; FEMALE; GLIOSIS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-12; MALE; MIDDLE AGED; PARKINSON DISEASE; PHAGOCYTES; PREDICTIVE VALUE OF TESTS; UP-REGULATION;

EID: 64549093797     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01103.x     Document Type: Article

References (45)

1. Boka G, Anglade P, Wallach D et al. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett 1994 172 : 151 4.
2. Mogi M, Harada M, Kondo T et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from Parkinsonian patients. Neurosci Lett 1994 180 : 147 50.
3. Mogi M, Harada M, Riederer P et al. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients. Neurosci Lett 1994 165 : 208 10.
4. Kim WG, Mohney RP, Wilson B et al. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 2000 20 : 6309 16.
5. Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990 39 : 151 70.
6. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988 38 : 1285 91.
7. Youdim MB, Riederer P. Understanding Parkinson's disease. Sci Am 1997 276 : 52 9.
8. Brosnan CF, Battistini L, Raine CS et al. Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 1994 16 : 152 61.
9. Chao CC, Hu S, Molitor TW et al. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992 149 : 2736 41.
10. Dickson DW, Lee SC, Mattiace LA et al. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993 9 : 75 83.
11. Espey MG, Chernyshev ON, Reinhard JF et al. Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport 1997 8 : 431 4.
12. Lee SC, Liu W, Dickson DW et al. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 1993 150 : 2659 67.
13. Lees GF. The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J Neurol Sci 1993 114 : 119 22.
14. Matsuo M, Hamasaki Y, Fujiyama F, Miyazaki S. Eicosanoids are produced by microglia, not by astrocytes, in rat glial cell cultures. Brain Res 1995 685 : 201 4.
15. Minghetti L, Levi G. Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J Neurochem 1995 6 : 2690 8.
16. Ma X, Trinchieri G. Regulation of interleukin-12 production in antigen-presenting cells. Adv Immunol 2001 79 : 55 92.
17. Jifen L, Bruno G, Guang-Xian Zhang et al. Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia. J Neurol Sci 2003 215 : 95 103.
18. Moore KW, O'Garra A, de Waal Malefyt R et al. Interleukin-10. Annu Rev Immunol 1993 11 : 165 90.
19. Sheng WS, Hu S, Kravitz FH et al. Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro. Clin Diagn Lab Immunol 1995 2 : 604 8.
20. Williams K, Dooley N, Ulvestad E et al. IL-10 production by adult human derived microglial cells. Neurochem Int 1996 96 : 55 64.
21. Bachis A, Colangelo AM, Vicini S et al. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 2001 21 : 3104 12.
22. Dietrich WD, Busto R, Bethea JR. Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp Neurol 1999 158 : 444 50.
23. Grilli M, Barbieri I, Basudev H et al. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci 2000 12 : 2265 72.
24. Molina-Holgado F, Grencis R, Rothwell NJ. Actions of exogenous and endogenous IL-10 on glial responses to bacterial LPS/cytokines. Glia 2001 33 : 97 106.
25. Chao CC, Hu S, Sheng WS, Peterson PK. Tumor necrosis factor-alpha production by human fetal microglial cells: regulation by other cytokines. Dev Neurosci 1995 17 : 97 105.
26. Larsen JP, Dupont E, Tandberg E. Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 1994 89 : 242 51.
27. Nagatsu T, Sawada M. Inflammatory process in Parkinson's disease: role for cytokines. Curr Pharm Des 2005 11 : 999 1016.
28. Qian L, Hong JS, Flood PM. Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin-10. J Neural Transm Suppl 2006 70 : 367 71.
29. Arimoto T, Choi DY, Lu X et al. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiol Aging 2006 28 : 894 906.
30. Cheeran MC, Hu S, Sheng WS et al. CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J Virol 2003 77 : 4502 15.
31. Marques CP, Hu S, Sheng W et al. Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia. Glia 2004 47 : 358 66.
32. Froen JF, Munkeby BH, Stray-Pedersen B, Saugstad OD. Interleukin-10 reverses acute detrimental effects of endotoxin-induced inflammation on perinatal cerebral hypoxia-ischemia. Brain Res 2002 942 : 87 94.
33. Hu S, Chao CC, Ehrlich LC et al. Inhibition of microglial cell RANTES production by IL-10 and TGF-beta. J Leukoc Biol 1999 65 : 815 21.
34. Mesples B, Plaisant F, Gressens P. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res 2003 141 : 25 32.
35. Kremlev SG, Palmer C. Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J Neuroimmunol 2005 162 : 71 80.
36. Szczepanic AM, Funes S, Petko W, Ringheim GE. IL-4, IL-10 and IL-13 modulate Abeta(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol 2001 113 : 49 62.
37. Szczepanic AM, Ringheim GE. IL-10 and glucocorticoids inhibit Abeta(1-42)-and lipopolysaccharide-induced proinflammatory cytokine and chemokine induction in the central nervous system. J Alzheimers Dis 2003 5 : 105 17.
38. Combarros O, Sanchez-Juan P, Riancho JA et al. Aromatase and interleukin-10 genetic variants modulate Alzheimer's disease risk. J Neural Transm 2008 115 : 863 7.
39. Rieckmann P, Albrecht M, Kitze B et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 1994 44 : 1523 6.
40. Pelfrey CM, Rudick RA, Cotleur AC et al. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production. J Immunol 2000 165 : 1641 51.
41. Waubant E, Gee L, Bacchetti P et al. Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS. J Neuroimmunol 2001 112 : 139 45.
42. Gangemi S, Basile G, Merendino AR et al. Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease. Mediators Inflamm 2003 12 : 251 3.
43. Bessler H, Djaldetti R, Salman H et al. IL-1β, IL-2, IL-6 and TNF-a production by peripheral blood mononuclear cells from patients with Parkinson's disease. Biomed Pharmacother 1999 53 : 141 5.
44. Rentzos M, Nikolaou C, Andreadou E et al. Circulating interleukin-15 and RANTES chemokine in Parkinson's disease. Acta Neurol Scand 2007 116 : 374 9.
45. Jason J, Archibald LK, Nwanyanwu OC et al. Comparison of serum and cell-specific cytokines in humans. Clin Diagn Lab Immunol 2001 8 : 1097 103.